Results 231 to 240 of about 178,517 (322)

The role of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells

, 2013
Kerstin Nündel, Patricia Busto, Michelle Debatis, Ann Marshak‐Rothstein   +3 more
openalex   +1 more source

Supplementary Data from Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase

, 2023
Yuqin Song, Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Haiyi Guo, Lei Zhou, Rebecca Elstrom, Jane Huang, William Novotny, Rachel Wei, Jun Zhu   +19 more
openalex   +1 more source

Retraction: X-linked immunodeficient mice with no functional Bruton's tyrosine kinase are protected from sepsis-induced multiple organ failure. [PDF]

Front Immunol
Frontiers Editorial Office.
europepmc   +1 more source

Inhibition of Bruton's Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization. [PDF]

Oxid Med Cell Longev, 2022
Yu M, Wu X, Peng L, Yang M, Zhou H, Xu J, Wang J, Wang H, Xie W, Kong H.   +9 more
europepmc   +1 more source

Bruton's Tyrosine Kinase and Protein Kinase C µ Are Required for TLR7/9-Induced IKKα and IRF-1 Activation and Interferon-β Production in Conventional Dendritic Cells

, 2014
Yanfeng Li, Koon-Guan Lee, Xijun Ou, Kong‐Peng Lam   +3 more
openalex   +2 more sources

Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis

, 2020
Jules Brochard, Florent Morio, Julien Mahé, Patrice Le Pape, Thomas Guimard, Beatrice Mahé, Marion Leterrier, Marine Morrier, F. Raffi, D. Boutoille   +9 more
openalex   +2 more sources

Pharmacologic Inhibition of Bruton's Tyrosine Kinase Attenuates Experimental Abdominal Aortic Aneurysms

JVS - Vascular Science, 2020
Baohui Xu, Yankui Li, Gang Li, Yingbin Ge, Jia Guo, Weirong Fang, Wei Wang, Fanru Shen, Takahiro Shoji, Toru Ikezoe, Xiaoya Zheng, Sihai Zhao, Xiaofeng Chen, Masaaki Miyata, Alan Daugherty, Hong Lu, Ronald L. Dalman   +16 more
doaj  

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor. [PDF]

JAAD Case Rep
Kucharik AH, Curkovic NB, Chavez JC, Tsai KY, Brohl AS, Grichnik JM.   +5 more
europepmc   +1 more source

Combination Treatment of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib and Carfilzomib in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Initial Results from a Multicenter Phase 1/2b Study

, 2015
Ajai Chari, Saurabh Chhabra, Saad Z. Usmani, Sarah Larson, Rubén Niesvizky, Jeffrey Matous, Cristina Gasparetto, Beata Holkova, Matthew A. Lunning, Jason Valent, Larry D. Anderson, Chatchada Karanes, Long Kwei, L. Chang, Thorsten Graef, Elizabeth Bilotti, Kevin T. McDonagh   +16 more
openalex   +1 more source

Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells

, 2016
Xianhui Wang, Jason Wong, Christopher J. Sevinsky, Leila Kokabee, Faiza Khan, Yan Sun, Douglas S. Conklin   +6 more
openalex   +1 more source